COVID-19-associated secondary sclerosing cholangitis - A case series of 4 patients

Clin Res Hepatol Gastroenterol. 2022 Dec;46(10):102048. doi: 10.1016/j.clinre.2022.102048. Epub 2022 Nov 5.

Abstract

We report a case series of four patients diagnosed with COVID-19-associated secondary sclerosing cholangitis (SSC), a recently described rare late complication of severe COVID-19. Following prolonged stays in the intensive care unit, these patients developed marked sustained cholestasis and jaundice despite clinical improvement. Cholangiography showed beaded appearance of intra-hepatic bile ducts and bile casts were removed in one patient. None of the patients reached normalization of liver enzymes and at least one progressed to liver cirrhosis (follow-up time of 11 to 16 months). COVID-19-associated SSC has a dismal prognosis with rapid progression to advanced chronic liver disease.

Keywords: COVID-19; Case series; Cholangiopathy; Secondary sclerosing cholangitis.

Publication types

  • Case Reports

MeSH terms

  • Bile Ducts, Intrahepatic
  • COVID-19* / complications
  • Cholangiography
  • Cholangitis, Sclerosing* / complications
  • Cholestasis* / complications
  • Humans